Off-Label Treatment of Alopecia Areata: Retrospective Study

    February 2026 in “ Biomedicines ”
    Julia Sternicka-Rohde, Leszek Bieniaszewski, Natalia Krzyżaniak … Dorota Purzycka-Bohdan
    Studysummary This retrospective study at the University Clinical Centre in Gdańsk reported that 77.9% of patients with alopecia areata were treated with off-label pharmacotherapy, predominantly glucocorticosteroids, highlighting a reliance on these therapies in European clinical practice.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on mdpi.com →
    Discuss this study in the Community →

    Research cited in this study 18

    1. Comparing the Efficacy of Oral Apremilast, Intralesional Corticosteroids, and Their Combination in Patients With Patchy Alopecia Areata: A Randomized Clinical Controlled Trial Archives of Dermatological Research · 2024
    2. Efficacy and Safety of Deuruxolitinib, an Oral Selective Janus Kinase Inhibitor, in Adults with Alopecia Areata: Results from the Phase 3 Randomized, Controlled Trial (THRIVE-AA1) Journal of the American Academy of Dermatology · 2024
    3. European Expert Consensus Statement on the Systemic Treatment of Alopecia Areata JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology · 2024
    4. Alopecia Areata: What's New in the Epidemiology, Comorbidities, and Pathogenesis? Journal of Dermatological Science · 2023
    5. Alopecia Areata: Diagnostic and Therapeutic Recommendations of the Polish Society of Dermatology. Part 2: Treatment Przegląd Dermatologiczny · 2023
    6. Treatment of Pediatric Alopecia Areata: A Systematic Review Journal of the American Academy of Dermatology · 2021
    7. Minoxidil for Patchy Alopecia Areata: Systematic Review and Meta-Analysis Journal of The European Academy of Dermatology and Venereology · 2019
    8. Controversies in Off-Label Prescriptions in Dermatology: The Perspective of the Patient, the Physician, and the Pharmaceutical Companies International Journal of Dermatology · 2018
    9. Comorbidities in Alopecia Areata: A Systematic Review and Meta-Analysis Journal of The American Academy of Dermatology · 2018
    10. Alopecia Areata Treated With Hydroxychloroquine: A Retrospective Study of Nine Pediatric Cases Pediatric dermatology · 2018
    11. Mesalazine in the Treatment of Extensive Alopecia Areata: A New Therapeutic Option? International Journal of Trichology · 2018
    12. Alopecia Areata: Overview and Insights from January 2018 Journal of The American Academy of Dermatology · 2017
    13. Methotrexate for the Treatment of Pediatric Alopecia Areata Journal of dermatological treatment · 2017
    14. Possible Advantage of Imiquimod and Diphenylcyclopropenone Combined Treatment Versus Diphenylcyclopropenone Alone: An Observational Study of Nonresponder Patients With Alopecia Areata Australasian journal of dermatology · 2016
    15. A Comparative Study of Oral Cyclosporine and Betamethasone Minipulse Therapy in the Treatment of Alopecia Areata Annals of dermatology/Annals of Dermatology · 2016
    16. Clobetasol Propionate, 0.05%, vs Hydrocortisone, 1%, for Alopecia Areata in Children JAMA dermatology · 2013
    17. The Safety and Efficacy of Diphencyprone for the Treatment of Alopecia Areata in Children Archives of dermatology · 2012
    18. Comparison of Treatment with Clobetasol Propionate 0.05% and Topical Pimecrolimus 1% in Alopecia Areata Journal of Dermatological Treatment · 2011